Ergoferon
- Generic Name
- Ergoferon
Efficacy and Safety of Ergoferon for COVID-19 Prevention During Vaccination Against SARS-CoV-2
- First Posted Date
- 2021-10-06
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 1057
- Registration Number
- NCT05069649
- Locations
- π·πΊ
City Clinical Hospital # 9 of the Ministry of Health of the Udmurt Republic, Izhevsk, Russian Federation
π·πΊCentral City Hospital # 7, Ekaterinburg, Russian Federation
π·πΊSpecialized Clinical Infectious Diseases Hospital/Vaccination room, Krasnodar, Russian Federation
Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2021-04-02
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 8411
- Registration Number
- NCT04413929
Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Viral Intestinal Infections in Children
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 259
- Registration Number
- NCT03039699
- Locations
- π·πΊ
Federal State Budgetary Institution of Higher Professional Education "Urals State Medical University" of the Ministry of Healthcare of the Russian Federation, Ekaterinburg, Russian Federation
π·πΊState budgetary Health Care institution of the Arkhangelsk region "Arkhangelsk Regional Pediatric Clinical Hospital named after PG Vyzhletsova", Arkhangel'sk, Russian Federation
π·πΊPirogov Russian National Research Medical University, Moscow, Russian Federation
Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children
- Conditions
- Acute Respiratory Viral Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-02-01
- Last Posted Date
- 2021-08-27
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 287
- Registration Number
- NCT03039621
- Locations
- π°πΏ
Kazakh Medical Continuing Education University, Almaty, Kazakhstan
π°πΏAstana Medical University, Astana, Kazakhstan
π·πΊMunicipal autonomous institution "Children's City Clinical Hospital β11", Ekaterinburg, Russian Federation
Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza
- First Posted Date
- 2013-05-09
- Last Posted Date
- 2020-04-16
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 184
- Registration Number
- NCT01850446
- Locations
- π·πΊ
Regional State Budgetary Healthcare Institution "Clinical Hospital β1", Smolensk, Russian Federation
π·πΊPirogov Russian National Research Medical University, Moscow, Russian Federation
π·πΊSt. Petersburg State Budgetary Health Care Institution " City policlinic No. 117", St. Petersburg, Russian Federation
Clinical Trial of Safety and Clinical Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Children
- Conditions
- Acute Upper Respiratory Tract Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-05-01
- Last Posted Date
- 2018-11-29
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 306
- Registration Number
- NCT01843842
- Locations
- π·πΊ
State Educational Institution of Higher Professional Education "Moscow State Medical Academy named after I.M. Sechenov", Moscow, Russian Federation
π·πΊState Budgetary Educational Institution of Higher Professional Education Novosibirsk State Medical University of Ministry of Health of Russian Federation, Novosibirsk, Russian Federation
π·πΊMunicipal Health Care Institution "City Child Health Clinical Polyclinic β5", Perm, Russian Federation
Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza
- First Posted Date
- 2013-03-05
- Last Posted Date
- 2015-06-23
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 161
- Registration Number
- NCT01804946
- Locations
- π·πΊ
St. Petersburg State Budgetary Health Care Institution "Π‘ity Polyclinic β 117", St. Petersburg, Russian Federation
π·πΊState Budgetary Educational Institution of Higher Professional Education "Smolensk State Medical Academy" of Ministry of Health and Social Development of Russian Federation, Smolensk, Russian Federation
π·πΊSt. Petersburg State Budgetary Health Care Institution "City Polyclinic β106", St. Petersburg, Russian Federation
Clinical Trial of Safety and Efficacy of Ergoferon in Liquid Dosage Form in Treatment of Acute Upper Respiratory Tract Infections in Adults
- Conditions
- Acute Upper Respiratory Tract Infections
- Interventions
- Drug: Placebo
- First Posted Date
- 2013-01-10
- Last Posted Date
- 2021-01-05
- Lead Sponsor
- Materia Medica Holding
- Target Recruit Count
- 342
- Registration Number
- NCT01765920
- Locations
- π·πΊ
St. Petersburg State Budgetary Health Care Institution "Medical Exercises Dispensary" of Krasnogvardeysky District, St. Petersburg, Russian Federation
π·πΊThe Non-governmental Health Care Institution "Road Hospital of the Open Joint Stock Company" Russian Railways", St. Petersburg, Russian Federation
π·πΊState Budgetary Educational Institution of Higher Professional Education "The Russian National Research Medical University named after N.I. Pirogov"/Outpatient Therapy Department of Medicine Faculty, Moscow, Russian Federation
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.